Coronary sinus reducer for the treatment of refractory angina: A randomised, placebo-controlled trial (ORBITA-COSMIC)
Reported from ACC.24
Aaysha Cader interviews Rasha Al-Lamee and Michael Foley about the results of the ORBITA-COSMIC trial presented at ACC.24 in Atlanta.
Results showed that coronary sinus reducer relieved angina symptoms but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its mechanism remains unclear.
Authors
No comments yet!